Trial Profile
Epacadostat With Cladribine and Cytarabine (ECC) in Relapsed / Refractory AML Patients Fit for Intensive Chemotherapy; a Phase I Study
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 19 Jun 2023
Price :
$35
*
At a glance
- Drugs Epacadostat (Primary) ; Cladribine; Cytarabine
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
- Acronyms ECC
- 07 Sep 2018 Status changed from not yet recruiting to withdrawn prior to enrolmentas IMP will not be further developed.
- 13 Apr 2018 New trial record